7篇
您的检索式：作者名="Philotheou"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial显示文摘 | Simon Heller John Buse Miles Fisher Satish Garg Michel Marre Ludwig Merker Eric Renard David Russell-Jones Areti Philotheou Ann Marie Ocampo Francisco Huiling Pei Bruce Bode | 2012 | The Lancet2012，，9825： | 2 |
| 2 | Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial显示文摘 | Bartley PC Bogoev M Larsen J Philotheou A | 2008 | Diabet Med2008，25，： | 1 |
| 3 | Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial显示文摘 | Bartley PC Bogoev M Larsen J Philotheou A | 2008 | Diabet Med2008，25，： | 1 |
| 4 | A randomized trialcomparing the rate of hypoglycemia-assessed using continuousglucose monitoring-in 125 preschool children with type 1 diabetestreated with insulin glargine or NPH insulin (the PRESCHOOLstudy) 显示文摘 | Danne T Philotheou A Goldman D | 2013 | PediatrDiabetes2013，14，8： | 1 |
| 5 | No effect of the altered peptide ligand NBI-6024 on beta-ceil residual function and insulin needs in new-onset type 1 diabetes 显示文摘 | Walter M Philotheou A Bonniei F | 2009 | Diabetes Care2009，32，11： | 1 |
| 6 | A randomized trial comparing the rate of hypoglycemia-assessed using continuous glucose monitoring- in 125 preschool children with type I diabetes treated with insulin glargine or NPI-I insulin(the PRESCtlOOI, study) 显示文摘 | Danne T Philotheou A Goldman D | 2013 | Pediatr Diabetes2013，14，8： | 1 |
| 7 | Comparable efficacy and safety of insulin glulisine and insulin lispro when given as part of a Basal-bolus insulin regimen in a 26-week trial in pediatric patients with type 1 diabetes显示文摘 | Philotheou A Arslanian S Blatniczky L | 2011 | Diabetes Technol Ther2011，13，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员